Notably, KDM4A overexpression was able to reverse the pro-apoptotic, cell cycle transition inhibitory, and growth inhibitory effects of RFX5 depletion in HCC cells, highlighting KDM4A is a dominant downstream effector of RFX5. This evidence concerns the gene KDM4A and hepatocellular carcinoma.